The erythrocyte sedimentation rate (ESR) Estimation of the erythrocyte sedimentation rate (ESR), now more appropriately referred to as the "length of sedimentation reaction in blood," has a long-standing history and tradition in clinical laboratories. 1 ESR, the most widely used laboratory measure of disease activity in clinical medicine, is still considered useful for monitoring inflammatory diseases, rheumatoid arthritis in particular. 2 Recent reviews and searches using MEDLINE indicate that this test is widely used both for the diagnosis and follow-up of patients with these conditions. [3] [4] [5] [6] In recent decades, several new techniques for measuring ESR have been developed and introduced in clinical laboratories to address the following needs: (1) to guarantee safety to operators by using automated and closed systems; (2) to automate the measurement itself and optimize the workflow and the utilization of human resources; (3) to create a unique workstation for measuring ESR and performing other hematologic tests (eg, erythrocyte, leukocyte, and reticulocyte concentrations) in a single specimen. This should be done, as suggested by the International Council for Standardization in Haematology (ICSH) and the National Committee for Clinical Laboratory Standards (NCCLS), by using the recommended specimen, undiluted blood with tripotassium (K 3 ) EDTA, which is more reliable than the traditional sodium citrate. 7, 8 Recently we evaluated and validated a new measurement procedure, the so-called TEST1 EC (SIRE Analytical System, Udine, Italy), which allows automated, safe, precise, and accurate measurement of the ESR in specimens collected in both sodium citrate and K 3 EDTA. 9 In an era of quality assurance and accreditation of medical laboratories, great attention should be given to the 
Estimation of the erythrocyte sedimentation rate (ESR), now more appropriately referred to as the "length of sedimentation reaction in blood," has a long-standing history and tradition in clinical laboratories. 1 ESR, the most widely used laboratory measure of disease activity in clinical medicine, is still considered useful for monitoring inflammatory diseases, rheumatoid arthritis in particular. 2 Recent reviews and searches using MEDLINE indicate that this test is widely used both for the diagnosis and follow-up of patients with these conditions. [3] [4] [5] [6] In recent decades, several new techniques for measuring ESR have been developed and introduced in clinical laboratories to address the following needs: (1) to guarantee safety to operators by using automated and closed systems; (2) to automate the measurement itself and optimize the workflow and the utilization of human resources; (3) to create a unique workstation for measuring ESR and performing other hematologic tests (eg, erythrocyte, leukocyte, and reticulocyte concentrations) in a single specimen. This should be done, as suggested by the International Council for Standardization in Haematology (ICSH) and the National Committee for Clinical Laboratory Standards (NCCLS), by using the recommended specimen, undiluted blood with tripotassium (K 3 ) EDTA, which is more reliable than the traditional sodium citrate. 7, 8 Recently we evaluated and validated a new measurement procedure, the so-called TEST1 EC (SIRE Analytical System, Udine, Italy), which allows automated, safe, precise, and accurate measurement of the ESR in specimens collected in both sodium citrate and K 3 EDTA. 9 In an era of quality assurance and accreditation of medical laboratories, great attention should be given to the issue of quality control and quality assurance for ESR measurement. Because the human erythrocyte sedimentation reaction is confined to fresh blood and is transient, reference or control materials of the usual type are not available. Stabilized specimens of human or nonhuman origin cannot be considered acceptable in place of fresh human blood or suitable for use in methods such as the TEST1 EC , which measure the kinetics of RBC sedimentation, not simply the final fall of RBCs after a fixed time.
The aim of the present study was to describe and evaluate a procedure based on the use of fresh human whole blood for the daily quality control of ESR in clinical laboratories.
Materials and Methods

Subjects
In this study, subjects were selected randomly from the entire population of both hospitalized and ambulatory patients. Blood samples were obtained and processed for analysis during routine work. Undiluted blood specimens anticoagulated with K 3 EDTA (Becton Dickinson System Europe, Meylan Cedex-France) were used for analysis. The samples were obtained in standardized conditions (collection in the morning after a night's fasting) and tested within 4 hours of venipuncture, according to ICSH recommendations. In each specimen, the concentrations of erythrocytes and leukocytes, the hemoglobin concentration, and the volume fraction of erythrocytes were further measured using the Coulter GenS System (Coulter, Miami, FL).
The TEST1 EC Analyzer
The TEST1 EC , a closed automated analyzer, determines the ESR in a standard-sized, closed vacuum tube with a perforating stopper. The tubes were placed in appropriate racks, and their content was mixed by slow rotation for about 3 minutes. The sample loader housed 4 racks holding 15 tubes each at the same time. The blood sample, withdrawn directly from the collection tube by a closed aspiration needle, was delivered into a capillary tube where it was accelerated via a "stopped flow" circuit, which causes the sedimentation of erythrocytes. The sensing area was maintained at a temperature of 37°C. The system uses an infrared-ray microphotometer with a light wavelength of 650 nm. The electrical pulses, collected by a photodiode detector, are directly correlated to the concentration of erythrocytes present at each capillary level. The pulses, measured per time unit, then are used to delineate the sedimentation curve for each sample by means of a mathematical algorithm. The mean decrease in the signal per time unit, called medium signal, and the square root of the integral signal were transformed to comparable Westergren values by a linear regression model.
Improvements recently were made to the original technique. Specifically, the rotation speed was increased from 16 to 60 rpm to achieve better, more complete mixing of blood. The system operates at a rate of 180 samples per hour in continuous loading, providing a result about every 20 seconds, and requires 150 µL of blood for each sample. The TEST1 EC plots the daily and the cumulative means of ESR values for 30 days before operation. Results are expressed in millimeters.
Comparison Between the Routine and the Westergren Method
Blood samples with TEST1 EC ESR values ranging from 2 to 120 mm were selected for comparison studies. The reference technique used for this was the Westergren method, which was performed according to the ICSH recommendation. 7 Briefly, 250-mm-long plastic tubes with a bore of 2.55 mm were used; all specimens, chosen from the routine samples, were EDTA-anticoagulated. The test was performed within 4 hours from venipuncture, and the blood was mixed carefully before mechanical aspiration. We then determined the bias, the agreement limits, and the 95% confidence interval (CI) of the routine method (TEST1 EC ) in comparison with the ICSH method (Westergren). The 95% CI of the mean bias was calculated for 10 representative groups of ESR values. We also compared the 2 methods using samples as the "reference materials." Samples were prepared following ICSH standardized recommendations (reference method), using patient blood samples with hematocrit values between 33% (0.33) and 35% (0.35).
Comparison Between Fresh and Stored Samples (Day-to-Day Control)
Throughout the study period, ESRs were measured in each sample within 4 hours after the blood collection and 24 hours after storage at 4°C. In 10 different representative groups of ESR values, we evaluated the bias, the agreement limits, and their 95% CIs.
Cumulative Mean Values
Every day for 20 days, we calculated the mean values of the average of data from 100 patients after which the mean, SD, and variation coefficient of the cumulative mean were calculated.
Statistical Analysis
The statistical analysis of data was carried out using MS Excel '98 software (Microsoft, Seattle, WA) to estimate the correlation factor, the linear regression, and the correlation between TEST1 EC and the Westergren method. The method comparison and the differences between ESR values from day to day were performed by using Bland-Altman analysis with the Astute package (Diagnostic Development Unit, University of Leeds, Leeds, England). The statistical analysis of the CI of data was achieved using the CIA (Confidence Interval Analysis) software, as presented by Gardner et ❚Figure 3❚ shows the data obtained by calculating the mean daily value for routinely collected specimens over time and the corresponding SDs and by reporting these data on a traditional quality control chart. The individual daily means ranged around the average mean (26.57 ± 3.81) and were always within ± 2 SDs.
The storage of 1,140 whole blood samples at 4°C for 24 hours caused a decrease in ESR values obtained by 2 different TEST1 EC analyzers with respect to the initial value: the mean differences were 2.86 (95% CI, 2.41-3.31) and 2.28 (95% CI, 1.90-2.65), respectively. This can be translated into mean percentage decreases of 9% and 11%, respectively, from one day to the next. By analyzing these data, we identified 10 groups of samples with different ESR values, and we obtained the bias, the agreement limits, and the 95% CI for each subgroup ❚Table 3❚. Moreover, we calculated the limits of acceptability for stored samples ❚Table 4❚, thus permitting the laboratory to easily monitor the day-to-day reliability of the assay system. 
Discussion
The ESR is still used widely in clinical practice as an indicator of inflammation, infection, trauma, or malignant disease, and several billion tests are performed every day in clinical laboratories throughout the world. Although Westergren developed the ESR method in the early 20th century, it has retained its status throughout the years, and the current reference method uses Westergren-type glass or plastic tubes and undiluted and nonhemolyzed blood specimens collected with the K 3 EDTA anticoagulant. Recently, we evaluated and validated a new automated measurement procedure, the socalled TEST1 EC , that allows automated, safe, precise, and accurate measurement of the ESR in clinical practice. The advantages of using this technique in clinical laboratories include safety for operators, full automation, reduced turnaround time, and limited analytic imprecision. However, the major advantage is, in our opinion, its use of undiluted K 3 EDTA-anticoagulated samples. It is well known that ESR is affected mainly by RBC aggregation or rouleau formation. The collection of specimens with K 3 EDTA enhances blood cell stability, thus favoring rouleau formation, preserving morphologic features, and obviating unphysiologic effects on the cells, and this is of crucial importance in the ESR reaction. As demonstrated by our findings, this type of anticoagulant and the premixing procedure used by TEST1 EC improve sample stability, thus allowing the measurement of the ESR after the time of 4 hours recommended by the NCCLS and simplifying the handling and transport of specimens. As the EDTA sample is used in most hematologic measurements, ESR analysis from the same sample would lead to further improvement: a smaller sample volume would be required (particularly useful in newborns, children, and oncology patients), sample collection and handling costs would be reduced, and hematologic estimations with ESR could be analyzed with a unique workstation, thus contributing to optimizing the workflow in clinical laboratories. Last, but not least, undiluted specimens anticoagulated with EDTA reduce the risk of preanalytic mistakes due to a partially coagulated specimen or to small clots, an altered blood/sodium citrate ratio, and problems linked to the final volume, inherent mainly in techniques using special tubes for both specimen collection and ESR measurement. 11, 12 While it is stated in textbooks that "the ESR procedure is more likely to be performed without quality control than any other common hematology test," 13 and the NCCLS states that "although the ESR procedure cannot be calibrated, it is inherently quite stable," in an era of quality assurance, certification, and accreditation, clinical laboratories must document the quality of ESR measurements. However, because of the nature of the human erythrocyte sedimentation reaction, reference or control materials of the usual type are not available for the ESR test, the sedimentation reaction being transient and confined to fresh blood. Although several stabilized specimens of human origin are available on the market and have been introduced in clinical laboratories, their kinetic properties, which are different from those of fresh blood erythrocytes, preclude their use for ESR determination using techniques such as the TEST1 EC , which assess the sedimentation rate rather than simply measuring the final fall of erythrocytes after 60 minutes. The NCCLS document recommends the verification of the working routine method against the reference method at a frequency determined by the laboratory standard operating procedure, particularly when any changes in pipettes, personnel, or other such variables are introduced. In addition, it suggests that currently the only feasible way of providing a control material is to specify a method for the production of such material in the laboratory where it is to be used. 8 We therefore evaluated a quality control procedure that uses fresh whole blood specimens. It is inexpensive and easy to perform in clinical laboratories. Because of the similar relationship observed between the reference method (Westergren) and the working technique (TEST1 EC ) in unselected specimens and in reference specimens (samples with a hematocrit of <35% [<0.35]), there is no need to preselect specimens on the basis of the hematocrit value. The average daily mean, which was relatively stable in our working conditions, should be used in the quality control procedure. The storage of samples at 4°C for 24 hours permits these specimens to be used for evaluating analytic imprecision, because the agreement limits for groups of specimens with different ESR values have now been defined. Finally, the comparison between the reference method and the TEST1 EC results guarantees the monitoring of accuracy over time. From a practical viewpoint, the quality control procedure is based on the following: (1) the calculation and monitoring of the daily cumulative mean, which is a relatively stable value when at least 100 specimens are analyzed in a consolidated clinical setting; the average value of this significant number of samples ranges within acceptable limits, with a coefficient of variation lower than 15%, and seems to be an adequate index for monitoring instrument performances; (2) comparison of fresh and stored samples, namely the measurement of three samples with different ESR values stored at 4°C for 24 hours, the allowable bias limits being defined for groups of specimens with different mean ESR values; and (3) comparison between results of the working method (TEST1 EC ) and those of the reference method. Again, we also have defined the allowable bias limits for groups of specimens with different ESR values.
While the daily cumulative mean of patient data should be monitored, and 3 samples stored for 24 hours should be measured every day, the routine TEST1 EC and the reference method should be compared once a week in stable conditions or at a shorter interval if any instrumental problems occur or the instrument setting has been modified for technical reasons. Clinical laboratories with a workload lower than 100 specimens per day could consider the cumulative mean on 200 to 300 ESR values measured in a few days. This information is provided directly by the instrument.
To identify "out-of-control" situations, we established the following reference procedures: (1) The limits of acceptable operation for the cumulative daily average are set at 3 ± SD of the mean. (2) At least 3 stored samples must be within the proposed limits of acceptability. (3) Concerning the comparability between the reference and the routine method, the latter must be considered "in-control" if 95% of results are within the limits of acceptability. (4) On adopting the Westgard rules in part, we considered the instrument out of control when the daily cumulative average values fell for 10 consecutive days on the same side of the mean. 14, 15 While quality control was once considered unimportant for ESR and for other hematologic tests, efforts should now be made to assure that adequate control materials and procedures are provided. Our results, obtained in fresh blood samples, demonstrate that with the TEST1 EC quality control for the measurement of ESR is feasible, inexpensive, and reliable. 
